Gilead Sciences to Present at the NASDAQ 18th Investor Program on Thursday, December 7

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it will
be webcasting a presentation on the company from the NASDAQ 18th
Investor Program in London, United Kingdom. This audio only webcast
may be accessed via the company's corporate website at www.gilead.com.

John F. Milligan, PhD, Gilead's Executive Vice President and Chief
Financial Officer, will provide an overview of the company on
Thursday, December 7 at 12:45 p.m. GMT (7:45 a.m. EST).

To access the live webcast via the internet, log on to
www.gilead.com. Please connect to the company's website at least 15
minutes prior to the live presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The
presentation will be archived for one week.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of unmet
medical need. The company's mission is to advance the care of patients
suffering from life-threatening diseases worldwide. Headquartered in
Foster City, California, Gilead has operations in North America,
Europe and Australia.

For more information on Gilead Sciences, please visit
www.gilead.com or call the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).